                         SEQUENCE LISTING

<110>  The Cleveland Clinic Foundation
 
<120>  cancer treatment using cx26 blocking peptides

<130>  CCF-025957 WO ORD

<150>  US 62/378,346
<151>  2016-08-23

<160>  30    

<170>  PatentIn version 3.5

<210>  1
<211>  20
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  1

Met Asp Trp Gly Thr Leu Gln Thr Ile Leu Gly Gly Val Asn Lys His 
1               5                   10                  15      


Ser Thr Ser Ile 
            20  


<210>  2
<211>  35
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 blocking peptide

<400>  2

Lys Glu Val Trp Gly Asp Glu Gln Ala Asp Phe Val Cys Asn Thr Leu 
1               5                   10                  15      


Gln Pro Gly Cys Lys Asn Val Cys Tyr Asp His Tyr Phe Pro Ile Ser 
            20                  25                  30          


His Ile Arg 
        35  


<210>  3
<211>  33
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  3

Arg His Glu Lys Lys Arg Lys Phe Ile Lys Gly Glu Ile Lys Ser Glu 
1               5                   10                  15      


Phe Lys Asp Ile Glu Glu Ile Lys Thr Gln Lys Val Arg Ile Glu Gly 
            20                  25                  30          


Ser 
    


<210>  4
<211>  38
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  4

Tyr Val Met Tyr Asp Gly Phe Ser Met Gln Arg Leu Val Lys Cys Asn 
1               5                   10                  15      


Ala Trp Pro Cys Pro Asn Thr Val Asp Cys Phe Val Ser Arg Pro Thr 
            20                  25                  30          


Glu Lys Thr Val Phe Thr 
        35              


<210>  5
<211>  11
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  5

Arg Tyr Cys Ser Gly Lys Ser Lys Lys Pro Val 
1               5                   10      


<210>  6
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  6

Met Asp Trp Gly Thr Leu Gln Thr Ile Leu 
1               5                   10  


<210>  7
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  7

Gly Gly Val Asn Lys His Ser Thr Ser Ile 
1               5                   10  


<210>  8
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  8

Lys Glu Val Trp Gly Asp Glu Gln Ala Asp 
1               5                   10  


<210>  9
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  9

Phe Val Cys Asn Thr Leu Gln Pro Gly Cys 
1               5                   10  


<210>  10
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  10

Leu Gln Pro Gly Cys Lys Asn Val Cys Tyr 
1               5                   10  


<210>  11
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  11

Asp His Tyr Phe Pro Ile Ser His Ile Arg 
1               5                   10  


<210>  12
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  12

Arg His Glu Lys Lys Arg Lys Phe Ile Lys 
1               5                   10  


<210>  13
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  13

Gly Glu Ile Lys Ser Glu Phe Lys Asp Ile 
1               5                   10  


<210>  14
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  14

Lys Ser Glu Phe Lys Asp Ile Glu Glu Ile 
1               5                   10  


<210>  15
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  15

Lys Thr Gln Lys Val Arg Ile Glu Gly Ser 
1               5                   10  


<210>  16
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  16

Tyr Val Met Tyr Asp Gly Phe Ser Met Gln 
1               5                   10  


<210>  17
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  17

Arg Leu Val Lys Cys Asn Ala Trp Pro Cys 
1               5                   10  


<210>  18
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  18

Pro Cys Pro Asn Thr Val Asp Cys Phe Val 
1               5                   10  


<210>  19
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  19

Ser Arg Pro Thr Glu Lys Thr Val Phe Thr 
1               5                   10  


<210>  20
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  20

Arg Tyr Cys Ser Gly Lys 
1               5       


<210>  21
<211>  6
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  Cx26 peptide fragment

<400>  21

Lys Ser Lys Lys Pro Val 
1               5       


<210>  22
<211>  13
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein transduction domain

<400>  22

Gly Arg Lys Lys Arg Arg Gln Arg Arg Arg Pro Pro Gln 
1               5                   10              


<210>  23
<211>  16
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein transduction domain

<400>  23

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


<210>  24
<211>  7
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein transduction domain

<400>  24

Arg Arg Met Lys Trp Lys Lys 
1               5           


<210>  25
<211>  18
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein transduction domain

<400>  25

Arg Gly Gly Arg Leu Ser Tyr Ser Arg Arg Arg Phe Ser Thr Ser Thr 
1               5                   10                  15      


Gly Arg 
        


<210>  26
<211>  10
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein transduction domain

<400>  26

Arg Arg Leu Ser Tyr Ser Arg Arg Arg Phe 
1               5                   10  


<210>  27
<211>  17
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein transduction domain

<400>  27

Arg Gly Gly Arg Leu Ala Tyr Leu Arg Arg Arg Trp Ala Val Leu Gly 
1               5                   10                  15      


Arg 
    


<210>  28
<211>  8
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  protein transduction domain

<400>  28

Arg Arg Arg Arg Arg Arg Arg Arg 
1               5               


<210>  29
<211>  51
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  29

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Lys Glu Val Trp Gly Asp Glu Gln Ala Asp Phe Val Cys Asn Thr Leu 
            20                  25                  30          


Gln Pro Gly Cys Lys Asn Val Cys Tyr Asp His Tyr Phe Pro Ile Ser 
        35                  40                  45              


His Ile Arg 
    50      


<210>  30
<211>  54
<212>  PRT
<213>  Artificial Sequence

<220>
<223>  synthetic peptide

<400>  30

Arg Gln Ile Lys Ile Trp Phe Gln Asn Arg Arg Met Lys Trp Lys Lys 
1               5                   10                  15      


Tyr Val Met Tyr Asp Gly Phe Ser Met Gln Arg Leu Val Lys Cys Asn 
            20                  25                  30          


Ala Trp Pro Cys Pro Asn Thr Val Asp Cys Phe Val Ser Arg Pro Thr 
        35                  40                  45              


Glu Lys Thr Val Phe Thr 
    50                  


